Nia Impact Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Nia Impact Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $205,719 - $264,656	-2,662 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$65.97 - $92.48 $670,453 - $939,874	-10,163 Reduced 79.24%	2,662 $246,000
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $34,828 - $43,548	502 Added 4.07%	12,825 $997,000
Q1 2021 Jun 16, 2021	BUY	$72.25 - $168.95 $187,777 - $439,101	2,599 Added 26.73%	12,323 $918,000
Q4 2020 Jan 25, 2021	BUY	$125.56 - $178.74 $1.22 Million - $1.74 Million	9,724 New	9,724 $1.64 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nia Impact Advisors, LLC with notifications on news.